Generic:
Tranexamic acid
Therapeutic Class:
Antifibrinolytic
Composition:
Each capsule of Maxna contains 500 mg tranexamic acid.Each 5 ml ampoule of Maxna contains 500 mg or 1gm of of tranexamic acid.
Description:
Maxna contains tranexamic acid, an antifibrinolytic agent, used to treat or prevent haemorrhage in a variety of bleeding disorders.
Indications:
Dosage:
Capsules: The usual adult dose of capsule is 500 mg three or four times daily depending on the severity of the condition.
Injection: For patients unable to take oral medication, Maxna injection can be administered in a dose of 10 mg/kg bodyweight 3 to 4 times daily.
Presentations: